Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

BACKGROUND: The FOLFOXIRI regimen produces a high rate of radiological and histopathological responses. Bevacizumab added to chemotherapy showed an improvement in pathological response and necrosis of colorectal liver metastases (CLMs). FOLFOXIRI plus bevacizumab produced promising early clinical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Loupakis, F, Schirripa, M, Caparello, C, Funel, N, Pollina, L, Vasile, E, Cremolini, C, Salvatore, L, Morvillo, M, Antoniotti, C, Marmorino, F, Masi, G, Falcone, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694238/
https://www.ncbi.nlm.nih.gov/pubmed/23703247
http://dx.doi.org/10.1038/bjc.2013.245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694238/
https://www.ncbi.nlm.nih.gov/pubmed/23703247
http://dx.doi.org/10.1038/bjc.2013.245

Ejemplares similares